Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The distinction matters because your approach to microdosing will determine what form of tirzepatide you need, how you measure it, and what results you can realistically expect
By activating both GIP and GLP-1 receptors, tirzepatide enhances glucose-dependent insulin secretion from pancreatic beta cells, suppresses inappropriate glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways
Failure or contraindication to step therapy
These considerations help ensure you make the best decision for your health circumstances
According to FDA guidelines, these medications are approved for people with a: A body mass index (BMI) of 30 or higher BMI of 27 or higher who have at least one weight-related health condition, like type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease These criteria help ensure that those most likely to benefit from treatment are prioritized
Tirzepatide offers a multitude of benefits for those struggling with type 2 diabetes and obesity
US$ 23.90
US$ 25.80
US$ 21.54
US$ 24.75
US$ 21.04
US$ 25.89
US$ 21.64
US$ 21.55
